Trulicity® is a GLP-1 RA that offers adults with type 2 diabetes

Proven HbA1c reduction 1

Ready-to-use pen 1

Once-weekly dosing 2

Trulicity® is a GLP-1 RA that offers adults with type 2 diabetes

Proven HbA1c reduction 1

Ready-to-use pen 1

Once-weekly dosing 2

Adverse event

Lilly primary concern is patient safety and we are committed to provide safe medications to our patients to make their life better. In case any patient experience any adverse events, kindly provide us with the following information to make sure that your report is completed:

  • One patient identifier (for example age, sex,…or other identifier)
  • Reporter contact information.
  • Lilly product.
  • The description of the event.

Even if you do not have all of the above information, please report your adverse event.

Please send your report to our Pharmacovigilance team by clicking on the link below: